Which of the following is a listed co-morbidity factor that indicates tibio-pedal access?

Study for the Healthcare Academy Exam. Prepare with quizzes and practice questions, each with detailed explanations. Ensure your readiness for healthcare certification.

Multiple Choice

Which of the following is a listed co-morbidity factor that indicates tibio-pedal access?

Explanation:
When deciding where to access the vessel for an endovascular procedure, clinicians weigh patient comorbidities to minimize risk. If pulmonary function is compromised, the safer path is often tibio-pedal access because it can be performed under local anesthesia with minimal respiratory depression, avoiding the deeper sedation or general anesthesia that can worsen breathing. This approach reduces respiratory risk while still achieving the needed reach to treat lower-extremity disease. Infected groin would steer away from femoral access due to infection risk, making pedal access more favorable for that reason. Vessel size and body habitus are more about anatomical feasibility than a systemic comorbidity, and inability to lie supine is a positioning/comfort issue rather than the direct respiratory-risk reduction that makes pedal access advantageous in the setting of poor pulmonary function.

When deciding where to access the vessel for an endovascular procedure, clinicians weigh patient comorbidities to minimize risk. If pulmonary function is compromised, the safer path is often tibio-pedal access because it can be performed under local anesthesia with minimal respiratory depression, avoiding the deeper sedation or general anesthesia that can worsen breathing. This approach reduces respiratory risk while still achieving the needed reach to treat lower-extremity disease.

Infected groin would steer away from femoral access due to infection risk, making pedal access more favorable for that reason. Vessel size and body habitus are more about anatomical feasibility than a systemic comorbidity, and inability to lie supine is a positioning/comfort issue rather than the direct respiratory-risk reduction that makes pedal access advantageous in the setting of poor pulmonary function.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy